Clinical Trial Update: Pharmacogenomic Modulators of Impaired Exercise Adaptation in Statin Users [NA]

View source ↗

Summary

Clinical trial update exploring pharmacogenomic factors that influence exercise adaptation in people taking statins, focusing on statin-related toxicity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Statin-induced Myopathy

Drugs mentioned

• Statins

Snippet

Sponsor: University of Kansas Medical Center | Conditions: HMG-CoA Reductase Inhibitor Toxicity | NA | Status: ACTIVE_NOT_RECRUITING